// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

A RANDOMIZED CONTROLLED TRIAL OF SPACED PRACTICE VERSUS MASSED TRAINING IN IMMERSIVE VIRTUAL REALITY HIP ARTHROPLASTY SIMULATION

Thomas Edwards - BRITISH ORTHOPAEDIC RESEARCH SOCIETY (BORS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

EFFECT OF STEM FIXATION, STEM MALALIGNMENT, AND BONE QUALITY IN TOTAL HIP ARTHROPLASTY: A FINITE ELEMENT STUDY

Katherine Wang - BRITISH ORTHOPAEDIC RESEARCH SOCIETY (BORS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

DOES THE TYPE OF SPORT INFLUENCE MORPHOLOGY OF THE HIP? A SYSTEMATIC REVIEW

Chantelle Doran - BRITISH ORTHOPAEDIC RESEARCH SOCIETY (BORS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

WHAT IS THE EVIDENCE FROM IN VIVO STUDIES THAT MESENCHYMAL STEM CELL-DERIVED EXTRACELLULAR VESICLES CAN FACILITATE TENDON AND LIGAMENT REPAIR?

Victor Lu - BRITISH ORTHOPAEDIC RESEARCH SOCIETY (BORS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

MECHANICAL LOADING UPREGULATES THE PIEZO1 CHANNEL IN HUMAN STEM CELL-DERIVED OSTEOCYTES

Sophie Gilbert - BRITISH ORTHOPAEDIC RESEARCH SOCIETY (BORS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

BILATERAL HIP RESURFACING ARTHROPLASTY RESTORES GAIT FUNCTION AT INCREASING WALKING SPEEDS

Amy Maslivec - BRITISH ORTHOPAEDIC RESEARCH SOCIETY (BORS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

GLUTAMATE SIGNALLING IN DOGS WITH CRANIAL CRUCIATE LIGAMENT DISEASE

Joel Alves - BRITISH ORTHOPAEDIC RESEARCH SOCIETY (BORS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

DIRECT INK WRITING OF POLYCAPROLACTONE/LAPONITE COMPOSITE FOR BONE IMPLANTS: 3D CHARACTERIZATION USING X-RAY MICRO CT

Hongyi Chen - BRITISH ORTHOPAEDIC RESEARCH SOCIETY (BORS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Prediction of drop-out and functional impairment in recent-onset schizophrenia spectrum disorders

A. Mucci - European Congress of Psychiatry (EPA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Schizophrenia

Clozapine

Shall we really say goodbye to first rank symptoms?

A. Heinz - European Congress of Psychiatry (EPA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Schizophrenia

N/A

Deconstructing Vulnerability for Psychosis: Meta-Analysis of Environmental Risk Factors for Psychosis in Subjects at Ultra High-Risk

P. Fusar-Poli - European Congress of Psychiatry (EPA) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Is avolition in schizophrenia associated with a deficit of dorsal caudate activity? A functional magnetic resonance imaging study during reward anticipation and feedback

A. Mucci - European Congress of Psychiatry (EPA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Schizophrenia

N/A

Unmet needs in patients with first-episode schizophrenia: a longitudinal perspective

K. Landolt - European Congress of Psychiatry (EPA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Schizophrenia

N/A

Characterization of well-differentiated bronchial epithelial cells derived from severe COPD patients

Hong Guo-Parke - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

GM-CSF

Genetic deletion of SLPI promotes inflammatory cell recruitment in a model of chronic lung disease

Ryan Brown - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

Elaszym

Alveolar type II cells harbouring SARS-CoV-2 show senescence with a proinflammatory phenotype

Koralia Paschalaki - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

Sulfasalazine

Dysregulation of ZFP36L1 and ZFP36L2 in severe asthma alters epithelial integrity and dampens genome-wide glucocorticoid responses

Rocio Teresa Martinez-Nunez - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

Glucocorticoid

Baseline characteristics of patients enrolled in the EARCO prospective registry of alpha-1 antitrypsin deficiency: preliminary results

Alice Turner - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Alpha-1 antitrypsin (A1AT) deficiency

Alpha 1-Antitrypsin

Relationship between baseline rescue medication use and reductions in COPD exacerbation rates: a subgroup analysis of the ETHOS trial

John R Hurst - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

Seebri Breezhaler

Raised FeNO in optimally-treated severe asthma identifies persistent eosinophilic chemotactic pull towards the airway

Simon Couillard - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

Interferon Gamma

Copyright © 2026. QuantiNova All rights reserved